Medical Insights from Industry

RSS
"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
Managing diabetes and intensive exercise: an interview with Dr Rafael Castol, Team Novo Nordisk

Managing diabetes and intensive exercise: an interview with Dr Rafael Castol, Team Novo Nordisk

Gaucher disease: an interview with Dr Clement Olivier, Shire

Gaucher disease: an interview with Dr Clement Olivier, Shire

Combating prescription drug abuse: an interview with Mark Trudeau and Carmen Catizone

Combating prescription drug abuse: an interview with Mark Trudeau and Carmen Catizone

Stages of symptoms in schizophrenia: an interview with Dr. Mark Opler, ProPhase

Stages of symptoms in schizophrenia: an interview with Dr. Mark Opler, ProPhase

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Aging healthily: an interview with Dr. Jack Watters, Vice President for External Medical Affairs, Pfizer

Aging healthily: an interview with Dr. Jack Watters, Vice President for External Medical Affairs, Pfizer

Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal

Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal

Cognitive impairment communication: an interview with Marc Wortmann, Executive Director, Alzheimer’s Disease International (ADI)

Cognitive impairment communication: an interview with Marc Wortmann, Executive Director, Alzheimer’s Disease International (ADI)

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

Tackling rising healthcare costs: an interview with Professor Graeme Currie, Warwick Business School

Tackling rising healthcare costs: an interview with Professor Graeme Currie, Warwick Business School

New spinal fixation technique: an interview with Dr. Ian Armstrong, Medical Director, Southern California Spine Institute

New spinal fixation technique: an interview with Dr. Ian Armstrong, Medical Director, Southern California Spine Institute

Chronic obstructive pulmonary disease flare-ups: an interview with Dr. MeiLan Han, University of Michigan and Scott Cerreta, Director of Education, COPD Foundation

Chronic obstructive pulmonary disease flare-ups: an interview with Dr. MeiLan Han, University of Michigan and Scott Cerreta, Director of Education, COPD Foundation

Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Genomics testing in action: an interview with Kevin Haar, CEO, Appistry

Genomics testing in action: an interview with Kevin Haar, CEO, Appistry

Pain control in osteoarthritis patients

Pain control in osteoarthritis patients

Fabry disease awareness: an interview with Dr. Hartmann Wellhoefer, Head of Medical Affairs, Rare Disease, Shire

Fabry disease awareness: an interview with Dr. Hartmann Wellhoefer, Head of Medical Affairs, Rare Disease, Shire

Treating ulcerative colitis and Crohn’s disease

Treating ulcerative colitis and Crohn’s disease

Preventing antibiotic side effects: an interview with Florence Séjourné, CEO, Da Volterra

Preventing antibiotic side effects: an interview with Florence Séjourné, CEO, Da Volterra

Evolution of multiple sclerosis treatments: an interview with Mike Panzara, Head of MS & Neurology Clinical Development, Genzyme

Evolution of multiple sclerosis treatments: an interview with Mike Panzara, Head of MS & Neurology Clinical Development, Genzyme

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.